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The effects of several antibiotics which are known to bind with 50 S ribosomal subunits, on the formation of 
several di- and tri-peptidyl puromycins have been examined. Tylosin and spiramycin inhibited the formation of 
phenylalanyl-‘4C-phenylalanyl-puromycin, glycyl-’ 4C-phenylalanyl-puromycin, leucyl-’ 4C-phenylalanyl-puromycin, 
Nkarbobenzoxylysyl-’ 4C-phenylalanyl-puromycin, and valylglycyl-‘4 C-phenylalanyl-puromycin as well as N-acetyl- 
“C-phenylalanyl-puromycin. Of these compounds, erythromycin and oleandomycin selectively inhibited the for- 
mation of phenylalanyl-‘4C-phenylalanyl-puromycin. Although chloramphenicol and lincomycin inhibited the for- 
mation of most of these peptidyl puromycins, the formation of phenylalanyl-’ 4C-phenylalanyl-puromycin and 
leucyl-‘4C-phenylalanyl-puromycin was found to be resistant to these antibiotics. So far, no significant effect of 
siomycin has been observed on peptidyl puromycin formation in the absence of G factor. 
1. Introduction 
It has been reported that puromycin reacts on 
ribosomes with polylysyl-tRNA [ 1,2] , polyphenyl- 
alanyl-tRNA [3], formyhnethionyl-tRNA [4,5], and 
N-acetyl-phenylalanyl-tRNA [6,7] in the absence of 
additional supernatant factors. These puromycin 
reactions have been studied as useful analogues of 
peptide bond formation. Recently a number of di- 
and tri-peptidyl tRNAs were chemically synthesized 
and their reaction with puromycin was studied [8] . 
This paper reports an investigation of the effect of 
several antibiotics, which have been shown to bind 
with 50 S ribosomal subunits, on the formation of 
peptidyl puromycin by Escherichia coli ribosomes. 
2. Materials and methods 
Ribosomes were prepared from E. coli Q13 and 
washed with an NH4C1 solution according to Pestka 
[9] .N-Acetyl-‘4C-phenylalanyl-tRNA was prepared 
by the method of Lapidot et al. [lo] . Peptidyl-tRNAs 
were prepared by condensation of N-hydroxy-succini- 
mide esters of o-nitrophenylsulfenyl amino acids or 
peptide with 14C-phenylalanyl-tRNA followed removal 
of the N-blocking group from the resulting o-nitro- 
phenylsulfenyl-peptidyl tRNA according to Lapidot 
et al. [ 1 l] . Peptidyl puromycin formation was 
assayed by measuring the puromycin dependent 
release of peptide from peptidyl tRNA [8, 121. The 
spontaneous release of peptides from each peptidyl 
tRNA was corrected for, using the value obtained in 
the absence of puromycin. Siomycin used in this 
study was a water soluble derivative (monothiomalic 
acid-siomycin A) [ 131 which was kindly supplied by 
Dr. Ebata and his collaborators in this laboratory. 
3. Results and discussion 
As shown in table 1, at quite low concentrations 
tylosin and spiramycin strongly inhibited all of the 
peptidyl puromycin reactions examined. Erythro- 
mycin and oleandomycin, which are also classified 
as macrolide antibiotics, as are tylosin and spiramycin, 
selectively inhibited phenylalanyl-14C-phenylalanyl- 
puromycin synthesis, the other peptidyl puromycin 
syntheses being resistant to these two antibiotics. 
Since chloramphenicol and lincomycin have been con- 
sidered to be inhibitors of the peptidyl transfer reac- 
tion [ 14, 151, it is interesting to note that compared 
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Table 1 
Effect of antibiotics on peptidyl puromycin synthesis. 
Antibiotics (pM) 
Peptidyl-PM 
N-AC-’ 4C-Phe-PM 
Gly-’ 4C-Phe-PM 
Phe-’ 4C-Phe-PM 
Leu-’ 4C-Phe-PM 
Ne-Cbz-Lys-’ 4C-Phe-PM 
Val-Gly-’ 4C-Phe-PM 
Ery Ole TY] Spi CAP Lin Sio 
(80) (80) (5) (5) (500) (800) (50) 
106% 112% 16% 15% 0% 9% 113% 
102 123 37 43 2 24 126 
22 23 19 34 77 86 99 
103 99 33 38 79 92 109 
92 93 13 41 39 67 130 
117 111 28 25 22 65 102 
The reaction mixture contained the following components in a final volume of 125 ~1: 50 mM tris-HCl (pH 7.8), 16 mM magne- 
sium acetate, 3.8 Aaeo units of ribosomes, approximately one Aa60 unit of peptidyl-tRNA (ca. 12,000 cpm), 50 pg of polyuri- 
dylic acid, 0.4 mM puromycin and 80 mM KCl. Incubation was carried out at 37’ for 15 min. After incubation, 50 ~1 aliquots 
were applied to filter paper discs and cold trichloroacetic acid precipitable unreacted peptidyl tRNA was assayed [121. 
The values obtained in the absence of antibiotics were taken as 100%. Ery: erythromycin, Ole: oleandomycin, Tyl: tylosin, Spi: 
spiramycin, CAP: chloramphenicol, Lin: lincomycin, Sio: siomycin, PM: puromycin, N-Ac-14C-Phe-PM: N-acetyl-14C-Phe-PM. 
Table 2 
Effect of oleandomycin and siomycin on N-acetyl-’ 4C-phenyl- 
alanyl-puromycin synthesis. 
N-Acetyl-’ 4C-phenylalanyl-puromycin 
formed (as cpm) in the presence of 
KC1 (mM) _ 
NH4Cl (mM) 
10 20 40 80 
160 
Exp. I 
Control 0 563 1085 1898 
Oleandomycin 
(160 /JM) 
480 1093 1819 2071 
Exp. 2 
Control 0 321 1165 1806 1970 
Siomycin 
(50 /JM) 
5 394 1253 1996 2105 
Reaction conditions were the same as described in the legend 
to table 1 except that the concentration of KC1 or NH4Cl was 
changed as cited. 
with the other peptidyl puromycins, the formations 
of phenylalanyl-14C-phenylalanyl-puromycin and 
leucyl-14C-phenylalanyl-puromycin were fairly resistant 
to both these antibiotics. Siomycin, which acts on 50 S 
ribosomal subunits [ 161 , showed no remarkable effect 
on peptidyl puromycin formation in the absence of G 
factor. 
We have previously found that erythromycin does 
not inhibit N-acetyl-14C-phenylalanyl-puromycin 
formation, and in fact stimulates it at low concentra- 
tion of K or NW4 where the puromycin reaction is 
normally hardly observed [ 171. A similar effect was 
observed with oleandomycin but not with siomycin, 
although it also does not inhibit N-acetyl-i4C-phenyl- 
alanyl-puromycin formation at sufficient concentra- 
tion of K+ or NH: (table 2). 
In this study, the compositions of the puromycin 
reaction mixtures were all the same, except for the 
different peptidyl tRNAs employed. Further, all the 
peptidyl tRNAs were derived from 14C-phenylalanyl- 
tRNA, thus the differences in the sensitivity of the 
puromycin reaction to the antibiotics among these 
peptidyl tRNAs should be mainly due to differences 
in the interaction between the 50 S ribosomal subunit 
site and the peptidyl end of the peptidyl tRNAs. As 
suggested by de Groot et al. [8], the affinity of pep- 
tidy1 tRNA to ribosomes may differ with the amino 
acid composition and chain length of the peptide at- 
tached to the tRNA. It has also to be noted that anti- 
biotics examined in this study may be classified into 
following four groups according to their effect on 
peptidyl puromycin formation: 1) erythromycin and 
oleandomycin; 2) tylosin and spiramycin, 3) chloram- 
phenicol and lincomycin, 4) siomycin. This classifica- 
tion is also supported by the previous findings that 
erythromycin, oleandomycin, chloramphenicol and 
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lincomycin inhibit polyadenylic acid dependent 
lysine incorporation to a much higher degree than 
polyuridylic acid dependent polyphenylalanjne syn- 
thesis [18] and that the binding of 14C-erythromycin 
to ribosomes is inhibited by the addition of an excess 
of oleandomycin, tylosin or spiramycin [ 191 but not 
by that of chloramphenicol [20] , lincomycin [21] , 
or siomycin (unpublished data), and that spiramycin, 
tylosin [22] and siomycin [23] strongly inhibit poly- 
phenylalanine synthesis. 
Considering these findings together, we may safely 
conclude that the binding of the respective antibiotics 
to ribosomes induces characteristic alterations in the 
conformation of the ribosome and consequent specific 
changes in the biological activity of the ribosome. 
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